Abstract: The present disclosure is intended to enhance various effects of a green tea extract such as catechin in the most effective manner. The ratio (B/A) of epigallocatechin gallate (A) contained in the green tea extract and flavanone glycoside (B) contained in the citrus extract is 0.2<B/A<1.6, or a ratio (C/A) of epigallocatechin gallate (A) and eriocitrin (C) contained in the citrus extract is 0.2<C/A<0.5.

Abstract: A fold line design method is a method for folding a target member. The method includes: setting a ribbase on a plane along a main surface of the target member; designing a plurality of first fold lines each of which extend radially from the ribbase as a starting point, and in which a mountain fold line and a valley fold line are alternately disposed; and designing a plurality of second fold lines which respectively connect the first fold lines adjacent to each other among the plurality of first fold lines, and constitute one continuous fold line.

Abstract: Provided is a method for producing an optically active substance, the method including an asymmetric induction, wherein an asymmetry inducer is allowed to act on a chiral molecule having a half-life of enantiomeric excess of shorter than 10 hours, thereby increasing abundance of one enantiomer of the chiral molecule. According to this method, one enantiomer of a chiral molecule that is susceptible to racemization can be selectively and efficiently obtained.

Abstract: A thermally conductive filler capable of exhibiting high thermal conductive properties with its specific gravity being reduced, a thermally conductive composite material and a wire harness that contains such a thermally conductive filler, and a method for forming a thermally conductive filler that can be used to form such a thermally conductive filler. A thermally conductive filler includes a hollow particle having a polar group on its surface, and a thermally conductive layer containing an inorganic compound that covers the surface of the hollow particle. Also, a thermally conductive composite material contains the thermally conductive filler and a matrix material, the thermally conductive filler being dispersed in the matrix material. Furthermore, a wire harness contains the thermally conductive composite material.

Abstract: Provided is an organic light-emitting element that is excited by an electromagnetic wave. The organic light-emitting element includes: a first electrode; a second electrode disposed to face the first electrode; an organic light-emitting layer disposed between the first electrode and the second electrode, where separation of charges occurs due to incidence of the electromagnetic wave; a hole transporting layer disposed between the first electrode and the organic light-emitting layer; and a charge block layer disposed between the second electrode and the organic light-emitting layer. The charge block layer has a LUMO level shallower than a LUMO level of organic light emitters included in the organic light-emitting layer.

Abstract: There are provided an aqueous electrolyte solution having an extended potential window, in particular, an aqueous electrolyte solution whose potential window is further wider than those exhibited by conventional concentrated aqueous electrolyte solutions, and an aqueous electrolyte solution in which the cycle characteristics can be improved. A non-aqueous electrolyte solution capable of achieving a higher energy density is provided, the non-aqueous electrolyte solution containing easily available and inexpensive materials and having further improved characteristics. One aqueous electrolyte solution of the present embodiment contains a salt of at least one selected from the group consisting of sodium, magnesium, potassium and lithium, and a chaotropic additive. One other non-aqueous electrolyte solution of the present embodiment contains a salt of at least one selected from the group consisting of sodium, magnesium, potassium and lithium, and a chaotropic additive.

Abstract: The present invention discloses a method for diagnosing cancer comprising a step of detecting active protein kinase C? in urine.

Abstract: The present invention provides a microstructure in which evenly distributed crystal grains line up in parallel lines extending along the surface of the film, and a no-lateral-growth region left at each of locations exposed to both ends of a grain interface, which serves as a partition between the neighboring two crystal grains. According to the present invention, there are also provided: a method for forming a polycrystalline film, such as a thin polycrystalline silicon film, a thin aluminum film, and a thin copper film, which is flat and even, in surface, electrically uniform and stable, and mechanically stable; a laser crystallization device for use in manufacture of polycrystalline films, and a semiconductor device using the polycrystalline film and having good electrical property and increased breakdown voltage.

Abstract: The present invention is to provide an adhesive composition which comprises a copolymer A which contains a recurring unit having a cyclic ether structure and a recurring unit having a benzophenone structure, and a copolymer B which contains a recurring unit having a betaine structure and a recurring unit having a hydroxyl group, a cured product thereof, and a method for producing the cured product. The adhesive composition of the present invention is capable of curing in water, has high hydrophilicity, and is capable of forming a cured product having an excellent ability to inhibit adhesion of biological substances.

Abstract: An organic electroluminescence device in which a polycyclic compound including an electron donor and an electron acceptor is included in an emission layer is provided. The electron donor contains an acridine derivative or a dibenzo-azasiline derivative, and the electron acceptor contains B as a ring-forming atom, O or S directly bonded to B, and a heterocyclic group in which three or five hexagonal rings are condensed. Accordingly, an organic electroluminescence device having high efficiency may be achieved.

Abstract: A medical polymer material in which a phosphate group having a C—O—P chemical bond including elemental C in a main chain of a structural formula is present on a surface of a polymer material substantially free of phosphate and hydroxy groups except for ends in the structural formula.

Abstract: Disclosed are a current excitation type organic semiconductor laser containing a pair of electrodes, an organic laser active layer and an optical resonator structure between the pair of electrodes and a laser having an organic layer on a distributed feedback grating structure. The lasers include a continuous-wave laser, a quasi-continuous-wave laser and an electrically driven semiconductor laser diode.

Abstract: A polymer compound in which a polymer chain containing a structure contributing to the inclusion of intermediate water is bound as at least a part of the organic component R group of a silsesquioxane.

Abstract: Provided is a catalyst which comprises a compound represented by formula (1) and which exhibits activity for at least one type of reaction selected from among hydrosilylation reaction or hydrogenation reaction with respect to an aliphatic unsaturated bond and hydrosilane reduction reaction with respect to a carbon-oxygen unsaturated bond or a carbon-nitrogen unsaturated bond. Formula (1): Mn(Lm) {M represents Fe, Co, or Ni having an oxidation number of 0, L represents an isocyanide ligand represented by formula (2), n denotes an integer of 1-8, and m denotes an integer of 2-12. Formula (2): (CN)x—R1 (R1 represents a mono- to trivalent-organic group having 1-30 carbon atoms, optionally being substituted by a halogen atom, and optionally having interposed therein one or more atoms selected from among O, N, S, and Si; and x denotes an integer of 1-3.)}.

Abstract: A method for hydrating a water-insoluble polymer capable of containing intermediate water, comprising; a solution generation step of dissolving a water-insoluble polymer capable of containing intermediate water by hydration in a polar organic solvent to obtain a solution, and a precipitation step hydrating and precipitating the water-insoluble polymer by mixing the solution with an aqueous phase.

Abstract: An arousal state estimation apparatus includes: a feature value acquisition unit acquiring a plurality of types of feature values regarding an arousal state of a human body from physiological data obtained by measuring the human body; and an estimation unit estimating the arousal state of the human body by using a principal feature value that is some type among the plurality of types of feature values. In a case where the principal feature value is unacquirable due to a defect of the physiological data, the estimation unit estimates the arousal state of the human body by using a different type of feature value than the principal feature value among the plurality of types of feature values acquired by the feature value acquisition unit instead of the unacquirable principal feature value.

Abstract: An object of the present invention is to provide a method for efficiently producing a heparin-like substance without using an animal-derived tissue. The present invention relates to a method for producing a heparin-like substance and the like, the method comprising: (1) preparing a mammalian cell that produces a heparin-like substance, (2) preparing a recombinant cell in which a gene that encodes an extracellular domain of syndecan is introduced into the mammalian cell that produces a heparin-like substance and is prepared in step (1), and (3) culturing the recombinant cell prepared in step (2) in a medium and collecting the heparin-like substance from the resulting culture supernatant.

Abstract: Stable perovskite films having substantially-no phase transition within a predetermined temperature range are disclosed. In the films, formation of carrier traps is suppressed. Thermally stable perovskite solar cells and light-emitting devices using the films are also disclosed.

Abstract: A surface protection composition contains (a) a phosphorus compound represented by formula (1), (b-1) a metal-containing compound or (b-2) an amine compound, (c) a (meth)acrylate having a hydrocarbon chain having 4 or more carbon atoms, (d-1) an acylphosphine oxide photopolymerization initiator and (d-2) an ?-aminoacetophenone photopolymerization initiator. Further, the composition has the compound (d-1) in an amount of 0.1 to 3.0 mass % with respect to the total amount of the composition, compound (d-2) in an amount of 0.1 to 3.0 mass % with respect to the total amount of the composition and a total amount of the compound (d-1) and (d-2) is less than 5.0 mass % with respect to the total amount of the composition. In the above formula, R1 represents a hydrogen atom, R2 represents a hydrocarbon group having 4 to 30 carbon atoms, and R3 represents a hydrogen atom or a hydrocarbon group having 4 to 30 carbon atoms.

Abstract: Provided is a labeling method for nucleic acid including a reaction step for hybridizing a nucleic acid probe that has a nucleotide sequence complementary to that of a nucleic acid to be labeled and contains a reactive nucleobase derivative incorporated at a position complementary to that of a target nucleobase as a target of labeling in the nucleic acid to be labeled, to the nucleic acid to be labeled; a transferring step for transferring a transfer group contained in the reactive nucleobase derivative to the nucleotide residue containing the target nucleobase in the nucleic acid to be labeled; and a labeling step for labeling the transfer group transferred to the nucleotide residue with a radioactive material.